ARQT
#1701
Arcutis Biotherapeutics, Inc. - Common stock
24.8 7 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.07%
Changement Mensuel
-11.84%
Evolution sur 6 mois
-3.23%
Changement Annuel
+60.14%
Clôture Précédente
25.1 4
Open
24.8 7
Low
24.8 7
High
24.8 7
Volume
119
Financials
- Market Capitalization 3.13 B
- Employee 354
- Founded 2016
- CEO Frank Watanabe
- Website www.arcutis.com
- Headquarter Delaware, United States
- FIGI BBG00QN8K4M4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-223.38
ratio cours/chiffre d'affaires
9.82
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1694 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.92 USD | +1.80% | +0.28% | +22.40% | +8.87% | 3.16 B USD | ||
| 1695 |  BEAM Beam Therapeutics Inc. - Common Stock | 30.48 USD | +0.96% | +6.05% | +16.38% | +80.68% | 3.15 B USD | ||
| 1716 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 15.21 USD | +10.78% | +12.09% | +51.49% | +680.00% | 3.07 B USD | ||
| 1736 |  ZLAB Zai Lab Limited - American Depositary Shares | 26.82 USD | +3.03% | +2.17% | +46.32% | +0.49% | 3.01 B USD |